To maintain a leading industry position, Akron is constantly adapting and responding to customers’ changing needs. At Akron Biotech, we are not simply a reagent distributor. We form a relationship, furnishing clients with comprehensive solutions to meet their specific needs. This means we provide regulation-approved raw materials (USP, EP, and JP grades) and biological reagents, from research grade to GMP grade. Furthermore, our products are supported by expert services that ensure regulatory compliance and a shorter time-to-market. Akron differentiates itself on its quality, consistency, and expertise. We’re well placed to grow significantly in a rapidly expanding market. As a global supplier, Akron manufactures and distributes components and raw materials for cell therapy discovery, development, and commercialization, meeting the industry’s needs worldwide. Our company’s unique business model emphasizes flexibility, quality, and unparalleled service—from research and development through clinical trial, market authorization, and commercial product.
EnoGene Biotech Co. Ltd, is a biological high-tech corporation that specializes in developing and production of antibody related products for biochemistry, molecular biology, immunology and other reagents in general laboratory use. EnoGene Biotech possesses advanced equipments, a highly experienced professional team, and the first class laboratory technology to offer the best products and services to universities, colleges, academes and institutes. At the same time, EnoGene Biotech focuses on transferring and developing the innovative research findings to reagent products. We will contribute to the development of biomedical research with our continuous new products.
Geno Technology, Inc. was founded in 1994 with a vision to simplify life science research. Our primary goal was to target the key techniques of protein research and find affordable methods to simplify and improve on these techniques. Over the years Geno Technology, Inc. has branched out into other areas of research, but our primary target still remains with proteins and our primary goal “simplify and improve on these techniques” still holds true. This message was reinforced in 2010 with the evolution of “The Protein Man”, our iconic mascot and the G-Biosciences brand. G-Biosciences’ team examined every aspect of particular experimental techniques, ranging from protein extraction to protein purification and detection, to identify key areas that we could target for improvement. As a result of this we now manufacture everything from simple buffers at convenient concentrations and sizes to custom manufactured devices, such as Tube-O-Dialyzer, that enhance and simplify key techniques. Our key areas we focused on included, but not limited to, protein assays, sample preparation, electrophoresis, Western blotting, mass spectrometry, assay development, antibody production and protein purification.
Reddot Biotech Inc., located in Kelowna, British Columbia, Canada, was founded in 2015 by an executive team with over 35 years combined experience in the medical device industry. We focus on providing customers in the global marketplace with timely customer service, reliable supply and products with superior performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sale of reagents and related products for pharmaceutical, laboratory, medical and scientific research use. We are committed to research and development to bring customers top quality products providing accurate, reliable and fast results critical to any research. With extensive experience working with companies and research institutes across continents, we offer tremendous value in the products and services we provide. We do our best to bridge the gap between the industry and academics, and welcome opportunities in collaboration to further scientific research.
HansaBioMed: leader in exosome based solutions for Life Sciences HansaBioMed OU is an innovative Company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTMplatform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.